CellCentric
Executivos
Veja o organograma con seus 20 executivos principais
Biografias mais buscadas da CellCentric
- Will West, Chief Executive Officer & Chairman of the Board
- Jason Dinges, Chairman of the Board
- Andrew Hughes, Non-Executive Director
Criar um alerta
para seguir os movimentos de executivos da CellCentric.
Saúde
CellCentric possui 1.818 concorrentes concorrentes Siemens Healthineers (Alemanha), IQVIA (Estados Unidos) e Saint Francis Health System (Estados Unidos).
Popular M&A news in Saúde
- Xaira Therapeutics se torna um unicórnio com sua arrecadação de fundos de 1.000 milhões de dólares. (publicado em 25 de abril de 2024).
- Two Chairs acaba de anunciar uma arrecadação de fundos de 72 milhões de dólares. (publicado em 18 de abril de 2024).
- Grow Therapy acaba de anunciar uma arrecadação de fundos de 88 milhões de dólares. (publicado em 12 de abril de 2024).
Outros contatos sugeridos na indústria do Saúde
Notícias
Últimos comunicados de imprensa de CellCentric
- CellCentric discloses significant new clinical data, demonstrating inobrodib’s efficacy in ongoing Phase I/IIa clinical trials – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114FFDC40D06-9F76-4E8A-AF33-68251D6B17C18B1E032
- CellCentric’s inobrodib’s novel mechanism: new data published in Cancer Cell – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114FFDC40D06-9F76-4E8A-AF33-68251D6B17C18B1E0328-3F62-4701-A135-6606C5F74CC55ED9A5DB-1645-4854-AF
- CellCentric secures further investment from BrightEdge, the American Cancer Society’s impact investment and innovation arm – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114F70F65CDB-84D7-4DBF-B9A3-94D23EB869978B1E0328-3F
- CellCentric announces $25m strategic investment from Pfizer – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114F70F65CDB-84D7-4DBF-B9A3-94D23EB869978B1E0328-3F62-4701-A135-6606C5F74CC5
- CellCentric Granted FDA Orphan Drug Designation for Inobrodib (CCS1477) for the Treatment of Multiple Myeloma – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114F70F65CDB-84D7-4DBF-B9A3-94D23EB869978B1E0328-3F62-4701-A135-
- CellCentric receives FDA Fast Track designation for inobrodib for the treatment of patients with relapsed refractory multiple myeloma – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114F70F65CDB-84D7-4DBF-B9A3-94D23EB86997
- CellCentric presents early clinical data at ASH – CellCentricFDC40D06-9F76-4E8A-AF33-68251D6B17C15ED9A5DB-1645-4854-AFCE-FF80DBBE114F70F65CDB-84D7-4DBF-B9A3-94D23EB869978B1E0328-3F62-4701-A135-6606C5F74CC5
- CellCentric to present haem clinical data at ASH
- CellCentric secures investment from the American Cancer Society’s impact venture capital fund
- CellCentric Strengthens Leadership Team
- View more press releases Close
Redes sociais sobre CellCentric
- CellCentric na Wikipedia, Google News e Yahoo Finance
- CellCentric na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Will West 
Ligue para a CellCentric em +44 179...
